Drugs.com FDA MedWatch AlertsOriginal article
FDA Adds Boxed Warning to Labeling for Ferric Carboxymaltose Injection (Injectafer) to Describe Risk of Low Phosphate Levels
RegulatoryapprovedInjectaferNegative
AI Analysis
Summary
The FDA approved a labeling revision for ferric carboxymaltose injection (Injectafer) that adds a boxed warning describing the risk of low phosphate levels. This regulatory update strengthens safety communication regarding a known adverse effect of the drug.
Outcome Details
FDA approved labeling revision adding boxed warning to describe risk of low phosphate levels
Importance:4/10
Sentiment:
-0.30
FDA Safety CommunicationBoxed WarningLabeling RevisionAdverse EffectDrug Safety
Related Companies
Read the original article
Published by Drugs.com FDA MedWatch Alerts on September 1, 2026 2:21 PM